文献速递炎症性肠病

克罗恩病合并潜伏性结核感染与肠结核:靶向下一代测序快速鉴别

Crohn's Disease With Latent Tuberculosis Infection or Intestinal Tuberculosis: Rapid Discrimination by Targeted Next-Generation Sequencing.
PubMed 文献 · Aliment Pharmacol Ther · 2025-02-04

前瞻性研究纳入100例未定性肠道溃疡且干扰素γ释放试验阳性的患者,其中肠结核66例、克罗恩病合并潜伏性结核感染34例。靶向下一代测序诊断肠结核的灵敏度83%、特异度100%,灵敏度显著高于抗酸染色、结核聚合酶链反应和干酪样坏死性肉芽肿检测;联合多临床因素模型灵敏度达97%。

要点

  • 靶向下一代测序诊断肠结核灵敏度83%、特异度100%,灵敏度和特异度均高。
  • 靶向下一代测序灵敏度显著高于抗酸染色15%、结核聚合酶链反应22%和干酪样坏死性肉芽肿检测17%。
  • 联合多临床因素模型灵敏度97%,高于单用靶向下一代测序的83%。

核心结论

  • 靶向下一代测序使用溃疡基底新鲜活检组织检测肠结核具有高灵敏度和特异度,优于其他传统诊断方法。
  • 靶向下一代测序可促进肠结核的快速诊断及与克罗恩病合并潜伏性结核感染的鉴别,尤其在高结核流行国家。

研究设计与样本

  • 前瞻性研究,于2020年9月至2023年12月开展。
  • 招募未定性肠道溃疡且干扰素γ释放试验阳性的患者。
  • 共纳入100例患者,其中肠结核66例,克罗恩病合并潜伏性结核感染34例。
  • 以抗结核治疗治愈及综合临床评估作为肠结核诊断依据。

主要发现

  • 靶向下一代测序诊断肠结核的灵敏度为83%(72%-91%),特异度为100%(87%-100%)。
  • 靶向下一代测序阳性预测值为100%(92%-100%),阴性预测值为76%(60%-87%)。
  • 靶向下一代测序灵敏度显著高于抗酸染色15%(4%-39%)、结核聚合酶链反应22%(12%-36%)和干酪样坏死性肉芽肿检测17%(9%-28%),p < 0.05。
  • 联合多临床因素模型灵敏度为97%,高于单用靶向下一代测序的83%。
  • 无克罗恩病合并潜伏性结核感染患者出现靶向下一代测序阳性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Discriminating Crohn's disease (CD) with latent tuberculosis infection (LTBI) from intestinal tuberculosis (ITB) in tuberculosis-endemic regions remains challenging. AIM: To assess whether targeted next-generation sequencing (tNGS) could be an efficient method for ITB diagnosis and discrimination from CD with LTBI. METHODS: The study was conducted prospectively from September 2020 until December 2023. We recruited patients with undetermined intestinal ulcers and positive interferon-gamma release assay. We compared tNGS (using fresh biopsy tissue samples from ulcer bases) to pathological detection of caseous necrotising granuloma, acid-fast bacillus (AFB) staining, tuberculosis polymerase chain reaction (TB-PCR) for diagnostic efficiency. ITB was diagnosed based on cure by anti-tuberculosis therapy and comprehensive clinical evaluation. RESULTS: Of the 100 patients included, 66 had ITB and 34 had CD with LTBI. The sensitivity, specificity, positive predictive value and negative predictive value of tNGS for ITB were 83% (72%-91%), 100% (87%-100%), 100% (92%-100%) and 76% (60%-87%), respectively. TNGS had significantly higher diagnostic sensitivity than AFB staining [15% (4%-39%), p < 0.05], TB-PCR [22% (12%-36%), p < 0.05] and detection of caseous necrotising granulomas [17% (9%-28%), p < 0.05]. The models combining multiclinical factors increased sensitivity (97% vs. 83%) than tNGS alone. No patients with CD and LTBI had positive tNGS. CONCLUSIONS: TNGS using fresh biopsy tissue from ulcer bases is highly sensitive and specific, with superiority over other traditional diagnostic methods for ITB detection. TNGS could facilitate rapid diagnosis of ITB and discrimination from CD with LTBI, particularly in high TB-endemic countries.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Ye L, Cao Y, Fu Y, et al. Crohn's Disease With Latent Tuberculosis Infection or Intestinal Tuberculosis: Rapid Discrimination by Targeted Next-Generation Sequencing. Aliment Pharmacol Ther. 2025. PMID: 39905821. doi:10.1111/apt.18522

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。